249 related articles for article (PubMed ID: 33112053)
1. Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
[TBL] [Abstract][Full Text] [Related]
2. Management of primary cutaneous lymphomas during the COVID-19 pandemic.
Mateeva V; Patsatsi A
Clin Dermatol; 2021; 39(1):64-75. PubMed ID: 33972055
[TBL] [Abstract][Full Text] [Related]
3. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
Geskin LJ; Kwinta BD; Garcia-Saleem TJ; Akilov OE; Enz PA; Guenova E; Ortiz-Romero PL; Papadavid E; Quaglino P; Rozati S; Stonesifer CJ; Burns A; Stringer WS; Tarin E; Scarisbrick JJ
J Am Acad Dermatol; 2023 Apr; 88(4):935-937. PubMed ID: 36375717
[No Abstract] [Full Text] [Related]
4. Cutaneous lymphoma: Kids are not just little people.
Ferenczi K; Makkar HS
Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
6. Paediatric cutaneous lymphomas: a review and comparison with adult counterparts.
Kempf W; Kazakov DV; Belousova IE; Mitteldorf C; Kerl K
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1696-709. PubMed ID: 25715748
[TBL] [Abstract][Full Text] [Related]
7. Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020.
Ohtsuka M; Hamada T; Miyagaki T; Shimauchi T; Yonekura K; Kiyohara E; Fujita H; Izutsu K; Okuma K; Kawai K; Koga H; Sugaya M
J Dermatol; 2021 Feb; 48(2):e49-e71. PubMed ID: 33245165
[TBL] [Abstract][Full Text] [Related]
8. [Epitheliotropic lymphomas: better identification for improved treatment].
Bagot M
Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
[No Abstract] [Full Text] [Related]
10. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.
Peterson E; Weed J; Lo Sicco K; Latkowski JA
Dermatol Clin; 2019 Oct; 37(4):455-469. PubMed ID: 31466586
[TBL] [Abstract][Full Text] [Related]
11. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
12. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the management of the cutaneous T cell lymphomas.
Zic JA
Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
[TBL] [Abstract][Full Text] [Related]
15. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
Burg G; Häffner A; Böni R; Dommann S; Dummer R
Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.
Ruiz R; Morante Z; Mantilla R; Mas L; Casanova L; Gomez HL
An Bras Dermatol; 2017; 92(5):649-654. PubMed ID: 29166501
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.
Glinos G; Wei G; Nosewicz J; Abdulla F; Chen PL; Chung C; Kaffenberger BH; Querfeld C; Shinohara MM; Sokol L; Zain J; Kumar A; Seminario-Vidal L
JAMA Dermatol; 2023 Feb; 159(2):192-197. PubMed ID: 36598766
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T cell lymphoma.
Dummer R; Vermeer MH; Scarisbrick JJ; Kim YH; Stonesifer C; Tensen CP; Geskin LJ; Quaglino P; Ramelyte E
Nat Rev Dis Primers; 2021 Aug; 7(1):61. PubMed ID: 34446710
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lymphomas management during COVID-19 pandemic.
Vitiello P; Sica A; Ronchi A; Pastore F; Casale B; Argenziano G
Ital J Dermatol Venerol; 2021 Apr; 156(2):248-249. PubMed ID: 33084270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
